The aim of this study is to evaluate the usefulness of the chronic obstructive pulmonary disease-population questionnaire (COPD-PS) and the COPD-6 device in the early detection of chronic obstructive pulmonary disease in smoker patients .
- Study Type: Observational
- Study Design
- Time Perspective: Other
- Study Primary Completion Date: March 15, 2020
- Other: Chronic obstructive pulmonary disease screening
- To verify the tobacco withdrawal, the patients will make a cooximetry. For the detection of a possible obstructive pattern a measurement of the ventilatory capacity will be make using the COPD-6 device and for the confirmation of COPD diagnosis and the assesment of the airflow obstruction severity a spirometry will be make. The patients will also complete the COPD-PS questionnaire.
Arms, Groups and Cohorts
- Tobacco detoxication cohort
- Patients appointed in a tobacco detoxication consultation
Clinical Trial Outcome Measures
- Evaluate the usefulness in the COPD early detection of the combination of the COPD-PS questionnaire and the COPD-6 device.
- Time Frame: Up to 12 months after the first consultation
- Verify if the combination of the COPDS-questionnaire (made of different items that allow the detection of chronic airflow obstruction) and the COPD-6 device (tool that measures the ventilatory capacity) is suitable for the COPD early detection.
Participating in This Clinical Trial
- > 35 years old
- Accumulative tobacco rate > 10 paq-year that go to the tobacco detoxication consultation
- Unable to fulfill the questionnarie
- Unable to adequately perform the COPD-6 or forced spirometry maneuvers included in the study.
- Reject to participate and sign the informed consent.
Gender Eligibility: All
Minimum Age: 35 Years
Maximum Age: N/A
Are Healthy Volunteers Accepted: No
- Lead Sponsor
- Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
- Provider of Information About this Clinical Study
- Overall Official(s)
- Agustín Valido Morales, Principal Investigator, Hospital Universitario Virgen Macarena
- Overall Contact(s)
- Agustín Valido Morales, 955 00 80 00, email@example.com
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.